Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma.

Minna Taskinen; Riku Louhimo; Satu Koivula; Ping Chen; Ville Rantanen; Harald Holte; Jan Delabie; Marja-Liisa Karjalainen-Lindsberg; Magnus Björkholm; Oystein Fluge; Lars Møller Pedersen; Karin Fjordén; Mats Jerkeman; Mikael Eriksson; Sampsa Hautaniemi; Sirpa Leppä

doi:10.1371/journal.pone.0091031

Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma.

Minna Taskinen, Riku Louhimo, Satu Koivula, Ping Chen, Ville Rantanen, Harald Holte, Jan Delabie, Marja-Liisa Karjalainen-Lindsberg, Magnus Björkholm, Oystein Fluge, Lars Møller Pedersen, Karin Fjordén, Mats Jerkeman, Mikael Eriksson, Sampsa Hautaniemi, Sirpa Leppä

Breastcancer-genetics

Research output: Contribution to journal › Article › peer-review

142 Downloads (Pure)

Abstract

Despite improved survival for the patients with diffuse large B-cell lymphoma (DLBCL), the prognosis after relapse is poor. The aim was to identify molecular events that contribute to relapse and treatment resistance in DLBCL.

Original language	English
Article number	e91031
Journal	PLoS ONE
Volume	9
Issue number	3
DOIs	https://doi.org/10.1371/journal.pone.0091031
Publication status	Published - 2014

Subject classification (UKÄ)

Cancer and Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1371/journal.pone.0091031Licence: CC BY

PLoS__Taskinen_et_al

http://www.ncbi.nlm.nih.gov/pubmed/24625556?dopt=Abstract

Cite this

Taskinen, M., Louhimo, R., Koivula, S., Chen, P., Rantanen, V., Holte, H., Delabie, J., Karjalainen-Lindsberg, M.-L., Björkholm, M., Fluge, O., Pedersen, L. M., Fjordén, K., Jerkeman, M., Eriksson, M., Hautaniemi, S., & Leppä, S. (2014). Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma. PLoS ONE, 9(3), Article e91031. https://doi.org/10.1371/journal.pone.0091031

@article{c0bc728c98484e75b2e484f7726f2614,

title = "Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma.",

abstract = "Despite improved survival for the patients with diffuse large B-cell lymphoma (DLBCL), the prognosis after relapse is poor. The aim was to identify molecular events that contribute to relapse and treatment resistance in DLBCL.",

author = "Minna Taskinen and Riku Louhimo and Satu Koivula and Ping Chen and Ville Rantanen and Harald Holte and Jan Delabie and Marja-Liisa Karjalainen-Lindsberg and Magnus Bj{\"o}rkholm and Oystein Fluge and Pedersen, {Lars M{\o}ller} and Karin Fjord{\'e}n and Mats Jerkeman and Mikael Eriksson and Sampsa Hautaniemi and Sirpa Lepp{\"a}",

year = "2014",

doi = "10.1371/journal.pone.0091031",

language = "English",

volume = "9",

journal = "PLoS ONE",

issn = "1932-6203",

publisher = "Public Library of Science (PLoS)",

number = "3",

}

Taskinen, M, Louhimo, R, Koivula, S, Chen, P, Rantanen, V, Holte, H, Delabie, J, Karjalainen-Lindsberg, M-L, Björkholm, M, Fluge, O, Pedersen, LM, Fjordén, K, Jerkeman, M , Eriksson, M, Hautaniemi, S & Leppä, S 2014, 'Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma.', PLoS ONE, vol. 9, no. 3, e91031. https://doi.org/10.1371/journal.pone.0091031

TY - JOUR

T1 - Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma.

AU - Taskinen, Minna

AU - Louhimo, Riku

AU - Koivula, Satu

AU - Chen, Ping

AU - Rantanen, Ville

AU - Holte, Harald

AU - Delabie, Jan

AU - Karjalainen-Lindsberg, Marja-Liisa

AU - Björkholm, Magnus

AU - Fluge, Oystein

AU - Pedersen, Lars Møller

AU - Fjordén, Karin

AU - Jerkeman, Mats

AU - Eriksson, Mikael

AU - Hautaniemi, Sampsa

AU - Leppä, Sirpa

PY - 2014

Y1 - 2014

N2 - Despite improved survival for the patients with diffuse large B-cell lymphoma (DLBCL), the prognosis after relapse is poor. The aim was to identify molecular events that contribute to relapse and treatment resistance in DLBCL.

AB - Despite improved survival for the patients with diffuse large B-cell lymphoma (DLBCL), the prognosis after relapse is poor. The aim was to identify molecular events that contribute to relapse and treatment resistance in DLBCL.

U2 - 10.1371/journal.pone.0091031

DO - 10.1371/journal.pone.0091031

M3 - Article

C2 - 24625556

SN - 1932-6203

VL - 9

JO - PLoS ONE

JF - PLoS ONE

IS - 3

M1 - e91031

ER -

Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma.

Abstract

Subject classification (UKÄ)

UN SDGs

Access to Document

Fingerprint

Cite this